Westport, CT, Nov. 01, 2023 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. BSGM (“BioSig” or the “Company”) a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, announced today that the U.S. Patent and Trademark Office has awarded several new utility patents covering the Company’s PURE…Read More
BioSig Adds Five New Patent Awards to 100 Total Patent Portfolio Covering Digital Signal Processing Technology and AI BioSig Technologies NASDAQBSGM
